Back
Omnicell 10K Form
Sell
33
OMCL
Omnicell
Last Price:
35.06
Seasonality Move:
1.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-03 | 10Q | OMCL/Omnicell Quarterly |
| 2023-08-04 | 10Q | OMCL/Omnicell Quarterly |
| 2023-05-05 | 10Q | OMCL/Omnicell Quarterly |
| 2022-11-04 | 10Q | OMCL/Omnicell Quarterly |
| 2022-08-09 | 10Q | OMCL/Omnicell Quarterly |
| 2022-05-09 | 10Q | OMCL/Omnicell Quarterly |
Receive OMCL News And Ratings
See the #1 stock for the next 7 days that we like better than OMCL
OMCL Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $42.82M |
| Price / Cash Flow: | 9.6 |
| Annual Sales: | $26.12 |
| Price / Book: | 1.34 |
Profitability
| EPS (TTM): | -0.77000 |
|---|---|
| Net Income (TTM): | $-34.4M |
| Gross Margin: | $588.99M |
| Return on Equity: | -2.99% |
| Return on Assets: | -1.56% |
Omnicell Earnings Forecast
Key Omnicell Financial Ratios
- The Gross Profit Margin over the past 23 years for OMCL is 45.45%.
- The Selling, General & Administrative Expenses for OMCL have been equal to 37.53% of Gross Profit Margin.
- The Research & Development expenses have been 8.10% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of OMCL is 0.44% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 15 years.
Omnicell Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Information Services |
| Sector: | Healthcare |
| Current Symbol: | OMCL |
| CUSIP: | 68213N |
| Website: | omnicell.com |
Debt
| Debt-to-Equity Ratio: | 0.48 |
|---|---|
| Current Ratio: | 2.47 |
| Quick Ratio: | 1.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 292.29 |
|---|---|
| Forward P/E Ratio: | 20.14 |